Breyanzi (lisocabtagene maraleucel) - BMS
Kymriah (tisagenlecleucel-T) - Novartis
Yescarta (axicabtagene ciloleucel) - Gilead
Actemra IV (tocilizumab) - Roche, JW Pharma, Chugai Pharmaceutical
https://www.sciencedirect.com/science/article/abs/pii/S2152265026032593
 
Sangam Sangam MD; Anuja Abhyankar MD
 
Sep 1, 2026
 
Prev Next